Diagnosis and support for your client's neurodiverse workforce
Our expert-led neurodevelopmental pathway is designed to make the diagnostic and support process for ADHD (Attention Deficit Hyperactivity Disorder), ASD (Autism Spectrum Disorder), and Tourette’s syndrome, faster and more accessible for your client's employees and their families.
Through the pathway, members can access the care they need without the usual wait times and discover tools to manage these conditions, giving them the space to be themselves and to feel more supported and motivated at work.
Product details
Why the neurodevelopmental pathway?
- With1 in 7 of the UK population though to be neurodivergent1, it’s likely your clients will have people in their teams with neurological conditions and disabilities
- The first step for members is making a call to our dedicated neurodevelopmental pathway claims helpline where they’ll be referred to our third-party clinical provider
- After an online screening assessment, employees are either referred to a third party clinical assessor or signposted to helpful resources. Any members that undergo clinical assessment and receive a diagnosis will then receive tailored support and one-on-one CBT (Cognitive Behavioural Therapy) sessions, alongside a comprehensive report
1. Neurodiversity; Workforce, Training and Education. NHS England, accessed February 2025. Contains public sector information licensed under the Open Government Licence v3.0.
For employees
- Access clinical support with a specialist clinician (psychiatrist or paediatrician) by self-referral into pre-assessment screening through our claims team
- The pathway is available for anyone, including children aged seven years and over
- Adapted CBT (where appropriate) that’s shaped by the employee's needs, treatment goals, and comfort levels
- Consultations with a clinical specialist for up to two years to support stabilisation and medication monitoring for ADHD (please note that this aspect of the service can only be accessed if the member has received their ADHD diagnosis through the neurodevelopmental pathway)
- If permission is given, information will be shared with the employee’s GP
For clients
- Creating a diverse and thriving workforce through supporting neurodiverse employees
- Helps to address the problems of overlooking neurodiversity such as expanding your talent pool, enabling people to be their most productive at work, and negating the detrimental impacts on employee wellbeing
- Having direct access to diagnosis and support means reasonable adjustments can be made, in turn helping neurodiverse employees feel more valued by their employer.
Our claims process
Step 1:
The employee will call our dedicated neurodevelopmental claims team, who will refer them to our third party provider.
Step 2:
After completing an online screening assessment with our third party provider, results will be analysed by a case manager. They’ll receive a comprehensive report which will outline the recommendations like adaptations at home, work, and school, if applicable. The report is routinely shared with the member’s GP, with consent. There are then two possible outcomes:
- If a more comprehensive assessment is needed, the employee will be referred to a clinical assessor. This will be either a psychiatrist or a paediatrician if the employee is acting on behalf of a child.
- If no further investigation is required, the employee will be signposted to other useful resources. Employees that don’t get a diagnosis on the neurodevelopmental pathway might benefit from our mental health pathway, if your client has selected this.
Step 3:
If the member receives a referral, they will then receive tailored support in line with the recommendations of their assessment, in-person or online. This might include adapted CBT. The therapist will complete reports about progress, which can be shared with the member’s GP.
If the member is provided with a private prescription, this will involve a cost for the medication. Please note that the cost of this may be more than the cost of getting the medication via a prescription from their GP or other NHS service*. There may also be additional costs involved e.g. the cost of issuing a private prescription or a charge made by the pharmacy.
* Shared Care Agreements and medication
A Shared Care Agreement is a formal arrangement between a specialist and a general practitioner (GP) to share the responsibility for prescribing and monitoring a patient’s medication. This agreement ensures that the patient receives coordinated and continuous care.
If the member receives a diagnosis of ADHD, medication may be offered to help manage the condition. Stimulant medications for ADHD are controlled drugs and need careful monitoring.
ADHD medication needs to be initiated by a specialist and the pathway provides benefit for the initial follow-up appointments (two appointments) to stabilise the medication and, following stabilisation of medication (also called ‘titration’), the member's clinician will usually ask their GP to take over prescribing under a Shared Care Agreement. A Shared Care request will only be initiated when the prescriber feels they are stable on medications and will not be made without appropriate consent.
There is no guarantee that their GP or local NHS services will accept the Shared Care request, this means that the member will have to continue paying for their medication on a private basis and also for the issuing/writing of the private prescription. They will also need to be referred to their local ADHD service to complete medication reviews following the end of their cover. There is likely to be a waiting list and waiting times will vary depending on their local service.
Useful documents
Employer facing
Our neurodiversity hub
Put diversity and inclusion at the centre of organisations. Learn more about neurodiversity from our neurodiversity hub resources.